Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Brain Dev. 2023 Mar;45(3):185-190. doi: 10.1016/j.braindev.2022.11.003. Epub 2022 Nov 24.
Pathogenic heterozygous variants in BICRA have recently been identified in patients with SWI/SNF-related intellectual disability (SSRIDD) - Coffin-Siris syndrome 12. So far, only one article reported SSRIDD associated with pathogenic variants in BICRA.
The patient's phenotype include low birth weight, microcephaly, neurodevelopment delay, visual, gastrointestinal, urinary tract impairment, and craniofacial dysmorphism. Whole exome sequencing revealed a novel pathogenic heterozygous variant in exon 6 of BICRA gene c.535C > T (p.(Gln179*)). Sanger sequencing confirmed de novo origin.
The clinical findings confirm and supplement the previous study which showed that pathogenic variant in BICRA is commonly characterized by neurodevelopmental, gastrointestinal, and ophthalmologic symptoms, growth retardation, as well as craniofacial dysmorphism.
BICRA 的致病性杂合变异体最近在伴有 SWI/SNF 相关智力障碍(SSRIDD)-Coffin-Siris 综合征 12 的患者中被发现。到目前为止,仅有一篇文章报道了与 BICRA 致病性变异体相关的 SSRIDD。
患者的表型包括低出生体重、小头畸形、神经发育迟缓、视力、胃肠道、泌尿道损害和颅面畸形。全外显子组测序显示 BICRA 基因外显子 6 中的一个新的致病性杂合变异 c.535C>T(p.(Gln179*))。Sanger 测序证实为新生突变。
临床发现证实并补充了之前的研究,表明 BICRA 的致病性变异通常表现为神经发育、胃肠道和眼科症状、生长迟缓以及颅面畸形。